Comparing two surgeries for esophageal cancer after prior treatment
Part of Cancer, Digestive system clinical trials.
This trial compares two types of surgery for esophageal cancer after you've already had chemotherapy, radiation, or immunotherapy. The goal is to see which surgery is better for removing the cancer and helping you recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- Your cancer must be a type called squamous cell carcinoma.
- The tumor must be in the chest area of the esophagus (not the neck or where it meets the stomach).
- You must have had chemotherapy, radiation, or immunotherapy before surgery.
- You must not have had any previous chest surgery or another current or past cancer.
- You must be able to give written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares adding immunotherapy to standard chemo-radiation before surgery for locally advanced, operable esophageal squamous cell cancer. It aims to improve how well the tumor responds and whether patients do better after surgery.
This trial tests giving a combination of chemotherapy, radiation therapy, and an immunotherapy drug before surgery for a type of esophageal cancer (squamous cell). The goal is to see if this approach helps shrink the tumor and improve outcomes for patients whose cancer can be surgically removed.
This trial studies whether additional treatment before surgery can improve outcomes for patients with esophageal squamous cell carcinoma. It focuses on those who have already received initial therapy and are scheduled for surgery.
This trial compares robot-assisted surgery with the standard open chest operation to remove esophagus and nearby tissue. It may help you understand which approach works better and is safer for patients whose cancer can be surgically removed.
This trial compares a robot-assisted approach to a standard minimally invasive approach for surgery in people with certain types of esophageal or gastroesophageal junction cancer that can be removed. It aims to see which surgery method works better and is safer for these patients.
This study compares two ways to perform surgery for esophageal cancer. The goal is to see if doing the surgery with minimally invasive techniques (using small incisions and cameras) is as safe and effective as a hybrid method that uses both small and larger incisions. Your participation may help doctors improve surgical options for future patients.
Hear when a new Surgical Procedure, Unspecified trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.